Allison Luo
Chief Tech/Sci/R&D Officer bij PROMETHEUS BIOSCIENCES, INC.
Profiel
Allison Luo is currently working as Senior VP-Gastroenterology at Biora Therapeutics, Inc. and as Chief Medical Officer at Prometheus Biosciences, Inc. She previously worked as Medical Director at Abbott Laboratories, Executive Director at Bristol Myers Squibb Co., and Vice President-Clinical Development at IVERIC bio, Inc. Dr. Luo completed her undergraduate and doctorate degrees from Northwestern University.
Actieve functies van Allison Luo
| Bedrijven | Functie | Begin |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01-08-2018 |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-06-2017 |
Eerdere bekende functies van Allison Luo
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 01-10-2014 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - |
Opleiding van Allison Luo
| Northwestern University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
